A clinical study to evaluate the effectiveness of Ksharapippali and Mahodarahara Kashaya in Vatashteela w.s.r to BPH
Phase 2
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2023/07/054658
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subject with signs and symptoms of Vatashteela (BPH).
2.Subject with mild to moderate BPH with score 1-19, as per The International Prostate Symptom
Score index.
Exclusion Criteria
1.Subject with malignancy.
2.Subject more than 80 years of age.
3.Subject with severe cardio vascular, Renal or Hepatic disorders, uncontrolled Hypertension &
Diabetes mellitus.
4.Subjects with immune compromised diseases.
5.Subject with USG findings suggestive of severe Hydroureteronephrosis.
6.Post-void Residual urine volume more than 100ml as assessed by USG of Abdomen and pelvis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in lower urinary tract symptomsTimepoint: 28 days
- Secondary Outcome Measures
Name Time Method Decrease in post void residual urine volume & reduction in enlargement of prostateTimepoint: 28 days